01
Metabolik & berat badan
Semaglutide
Type 2 diabetes, chronic weight management and product-specific approved indications.
GLP-1 receptor (GLP-1R) agonist.
Peptide finder
Terokai katalog mengikut ciri
Gunakan kategori, tahap bukti, status regulator dan sasaran biologi untuk pembelajaran. Hasil bukan diagnosis atau cadangan rawatan.
Penapis pendidikan59 padanan
02
Metabolik & berat badan
Tirzepatide
Type 2 diabetes and chronic weight management under product-specific labels.
Dual GIP receptor and GLP-1 receptor agonist.
03
Metabolik & berat badan
Retatrutide
Investigational therapy for obesity and metabolic disease; not routine treatment.
Triple GLP-1R, GIPR and glucagon receptor agonist.
04
Paksi GH & pertumbuhan
Somatropin (HGH 191AA)
Growth-hormone deficiency and selected growth disorders through licensed prescription products.
Growth hormone receptor, with downstream IGF-1 effects.
05
Metabolik & berat badan
SLU-PP-322
Experimental compound studied in preclinical metabolism and endurance models.
Pan-ERR agonist, especially estrogen-related receptor alpha/gamma in preclinical work.
06
Neurologi, kognitif & tidur
Pinealon
Marketed as a peptide bioregulator; high-quality clinical evidence is limited.
No primary human receptor has been confirmed.
07
Imuniti & keradangan
LL-37
Endogenous antimicrobial peptide studied in immunity and wound biology.
Interacts with FPR2, P2X7 and membranes; not a single-receptor drug.
08
Reproduktif & kesihatan seksual
PT-141 (Bremelanotide)
Vyleesi is indicated for selected premenopausal women with acquired generalized HSDD; it is not a general performance enhancer.
Melanocortin receptor agonist, mainly MC4R and MC3R.
09
Neurologi, kognitif & tidur
Selank
Studied or marketed for anxiety and cognition; evidence and registration vary by country.
Reported GABA and neurotrophin modulation; a direct primary receptor is not established.
10
Reproduktif & kesihatan seksual
Oxytocin acetate
Induction or augmentation of labour and management of postpartum bleeding in clinical settings.
Oxytocin receptor agonist.
11
Neurologi, kognitif & tidur
Epithalon
Marketed for anti-ageing, but human evidence and product standards are insufficient.
No validated primary receptor; telomerase claims do not establish an approved indication.
12
Pemulihan & pembaikan tisu
BPC-157
Experimental peptide marketed for tendon, gut and wound recovery; human evidence is very limited.
No confirmed primary human receptor; proposed pathways include NO and VEGF signalling.
13
Pemulihan & pembaikan tisu
BPC-157 + TB-500
Experimental combination marketed for tissue recovery.
BPC-157 target is unconfirmed; TB-500 is associated with actin binding.
14
Mitokondria & tenaga sel
SS-31 (Elamipretide)
Forzinity is approved to improve muscle strength in patients with Barth syndrome weighing at least 30 kg; other uses remain investigational.
Binds cardiolipin in the inner mitochondrial membrane rather than a classic surface receptor.
15
Paksi GH & pertumbuhan
CJC-1295 tanpa DAC
Experimental GHRH analogue intended to stimulate growth-hormone release.
GHRH receptor agonist.
16
Paksi GH & pertumbuhan
CJC-1295 tanpa DAC + Ipamorelin
Experimental combination intended to stimulate the GH axis.
GHRH receptor plus ghrelin receptor/GHS-R1a.
17
Paksi GH & pertumbuhan
CJC-1295 dengan DAC
Long-acting GHRH analogue used in research.
GHRH receptor agonist; DAC extends exposure through albumin binding.
18
Neurologi, kognitif & tidur
DSIP
Delta sleep-inducing peptide with weak and inconsistent human efficacy evidence.
No specific DSIP receptor has been validated.
19
Neurologi, kognitif & tidur
Melatonin
Circadian signal used for sleep-related purposes; its legal category varies by country.
MT1 and MT2 melatonin receptor agonist.
20
Kulit, rambut & pigmentasi
MT-1 (Melanotan I)
Alpha-MSH analogue; approved afamelanotide is used for selected EPP patients, not general cosmetic tanning.
Primarily a melanocortin-1 receptor agonist.
21
Kulit, rambut & pigmentasi
MT-2 (Melanotan II)
Experimental peptide marketed for tanning and libido.
Agonist at several melanocortin receptors including MC1R, MC3R and MC4R.
22
Neurologi, kognitif & tidur
Semax
Studied or marketed for neurological and cognitive uses in some countries.
No agreed primary receptor; BDNF and melanocortin-related effects are reported.
23
Neurologi, kognitif & tidur
Semax + Selank
Experimental combination without validated clinical combination evidence.
Primary targets for both peptides remain uncertain.
24
Pemulihan & pembaikan tisu
TB-500 (Thymosin beta-4 fragment)
Experimental fragment marketed for tissue repair.
Associated with actin and cell migration rather than one classic receptor.
25
Reproduktif & kesihatan seksual
hCG
Prescription therapy for selected fertility and hypogonadism indications.
LH/CG receptor agonist.
26
Metabolik & berat badan
AOD-9604
Experimental hGH fragment marketed for body-fat reduction.
Human mechanism is not confirmed and it is not a full GHR agonist.
27
Paksi GH & pertumbuhan
IGF-1 LR3
Long-acting IGF-1 analogue used in research.
IGF-1 receptor agonist with possible insulin-receptor cross-activity.
28
Paksi GH & pertumbuhan
Tesamorelin
Reduction of excess abdominal fat in adults with HIV and lipodystrophy; not general weight-loss treatment.
GHRH receptor agonist that increases endogenous GH and IGF-1.
29
Paksi GH & pertumbuhan
Ipamorelin
Experimental growth-hormone secretagogue.
Ghrelin receptor/GHS-R1a agonist.
30
Kulit, rambut & pigmentasi
AHK-Cu
Copper-binding tripeptide studied for skin and hair applications.
Copper binding and gene-expression effects; no single primary receptor.